08 June 2012 | News | By BioSpectrum Bureau
Takeda acquires URL Pharma
Takeda acquires URL Pharma for $800M
Singapore: Takeda Pharmaceutical Company acquired URL Pharma through its wholly-owned subsidiary Takeda America Holdings (TAH), for an upfront payment of $800 million in cash and future performance-based contingent earn out payments. Following the acquisition, Takeda Pharmaceuticals, US, will now manage URL Pharma, whose major shareholders include Elliott Associates, Momar Corporation and Richard H Roberts.
For the year ending 2011, URL Pharma generated nearly revenues of $600 million, with approximately 500 employees and has a contracted a sales force consisting of approximately 350 individuals. Goldman Sachs and Sidley Austin are acting as financial and legal advisors, respectively, to TAH, and JP Morgan Securities and Ropes & Gray are acting as financial advisor and legal counsel, respectively, to URL Pharma. TAH is engaged in handling cash management and investment activities, while Takeda Pharmaceutical is a Japanese research-based global pharmaceutical company.